Dr. Reddy's Laboratories gets one observations from USFDA for Hyderabad facility

06 May 2023 Evaluate

The United States Food & Drug Administration (USFDA) has completed a routine GMP inspection at Dr. Reddy's Laboratories’ API manufacturing facility (CTO 1) in Bollaram, Hyderabad. The company has been issued a Form 483 with one observations, which it will address within the stipulated timeline. The inspection was conducted from May 1, 2023 to May 5, 2023. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1224.20 -15.80 (-1.27%)
28-Jan-2026 13:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.30
Dr. Reddys Lab 1224.20
Cipla 1316.40
Zydus Lifesciences 893.60
Lupin 2125.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×